1.
The Off-Patent Biological Market in Belgium: Is the Health System Creating a Hurdle to Fair Market Competition?
The impact of policy interventions to promote the uptake of biosimilar medicines in Belgium: a nationwide interrupted time series analysis
Perceptions About Biosimilar Medicines Among Belgian Patients in the Ambulatory Care
2.
3.
Determinants of prescribing decisions for off-patent biological medicines in Belgium: a qualitative study
Cost–DALY comparison of hip replacement care in 12 Belgian hospitals